SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Magazine Features

Despite obstacles, 3-D mammo is making huge strides With reimbursement around the corner, the sector may explode

Imaging children Playing up kid-friendly imaging will improve your bottom line

Angst over Amyvid: is CMS being short-sighted? CMS says "no" and the market says "yes"

PET Isotopes What role will mini cyclotrons play?

Q&A with Amy Knight The COO for Children's Hospital Association talks about the unique challenges faced when treating children

See All Magazine Features  

More Industry Headlines

GE and GlaxoSmithKline team up for oncology testing Working to standardize diagnostic testing

Boosting access to primary care Increasing amount of physicians is not the answer

Federal government weighs in on antibiotic resistance Issues national strategy and calls for alternative treatments

A protein can speed up recovery after radiation and chemo Shows promise in animal experiments

Patient engagement solutions market expected to soar Will hit $13.7 billion by 2019

Big data platform designed for new value-based model Helps physicians improve outcomes while reducing costs

Hospitals saving billions on charity care ACA may save expansion state hospitals up to $4.2 billion in 2014

FDA approves GE's new PET/CT Higher sensitivity and field-of-view

Consensys joins forces with Oncology Services International A strategic alliance among ISOs

Checking in with the first installed MEVION S250 Assessing nine months of single room proton therapy

Nanomedicine: The Magic Bullet?

by Loren Bonner , DOTmed News Online Editor
This story first appeared in the April 2012 issue of DOTmed HealthCare Business News

Advances in the field show promise for what seemed like wishful thinking only a century ago.

Glioblastoma, the brain tumor that killed U.S. Senator Edward “Ted” Kennedy in
2009, is one of the most common—and most aggressive—types of brain tumor there is. Once a diagnosis is confirmed, a patient’s typical course of treatment is surgery. But tumor removal is a tactile and visual procedure. Oftentimes, a surgeon can’t recognize and remove every single piece of cancerous tissue. In turn, this can cause tumor re-growth in a patient and the causalities that may follow.

Story Continues Below Advertisement

We want to buy your Siemens Symphony or Avanto MRI -- today!

Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250 DOTmed Certified



Nanomedicine, or the application of science at the nanometer or molecular scale, has the potential to change this. Using nanotheranostics – a combining of therapeutic and diagnostic techniques in nanomedicine – researchers at Stanford University have developed an imaging technology that specifically detects Glioblastoma cancer cells, along with a novel approach to destroying them.

“We have nanoparticle-based imaging agents that can be injected into tumor sites,” says Dr. Demir Akin, deputy director of Stanford University’s Center for Cancer Nanotechnology Excellence and Translation. “Because tumor sites have leaky blood vessels due to the gaps between the cells, the nanoparticles can go through those gaps.”

According to Akin, paired with infrared light, nanoparticles built to locate and infiltrate cancer cells can be used in an imaging capacity (the diagnostic portion) and since the infrared light is absorbed by the nanoparticles, the tissue containing the particles is, in turn, heated. Ultimately, this leads to the destruction of the metastatic tumor tissue.

“It is impossible to say how many nanomedicine research projects are ongoing globally at the current time, but it is certainly a rapidly expanding field,” says Ruth Duncan, co-author of “Nanomedicine(s) under the Microscope,” which provides a review of the history and evolution of nanomedicines, as well as the emerging opportunities to come.

Duncan says that nanotechnologies are being developed for applications in health care and medicine in several different ways. Nanomedicine can provide new surgical tools and devices that can be used outside the patient, and it can offer biomaterials to aid in tissue repair and drug delivery (often combined with cell therapy). As for disease, innovations are three-fold: diseases can be more accurately imaged and monitored during treatment, and therapies can be individualized and precisely targeted for better outcomes.

Continue reading Nanomedicine: The Magic Bullet?...
  Pages: 1 - 2 - 3 - 4 - ... >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED